Xsensio Revenue and Competitors

Lausanne,

Location

N/A

Total Funding

Technology

Industry

Estimated Revenue & Valuation

  • Xsensio's estimated annual revenue is currently $1.2M per year.(i)
  • Xsensio's estimated revenue per employee is $121,200

Employee Data

  • Xsensio has 10 Employees.(i)
  • Xsensio grew their employee count by -37% last year.

Xsensio's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$46.2M2081%N/AN/A
#2
$57.1M263-20%N/AN/A
#3
$221.4M78318%N/AN/A
#4
$23.4M11633%N/AN/A
#5
$34M1537%N/AN/A
#6
$20.8M1037%N/AN/A
#7
$10M5538%N/AN/A
#8
$32.2M1457%N/AN/A
#9
$20.2M1005%$125.1MN/A
#10
$24.2M12012%N/AN/A
Add Company

What Is Xsensio?

Xsensio develops the unique Lab-on-Skinâ„¢ sensing platform for next-gen wearables. It senses in real-time biochemical information at the surface of the skin, providing unprecedented real-time information about our health and wellness, in a simple and non-invasive way. Xsensio is a B2B company, offering Lab-on-Skinâ„¢ solutions to consumer care and consumer electronics companies.

keywords:N/A

N/A

Total Funding

10

Number of Employees

$1.2M

Revenue (est)

-37%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Xsensio News

2022-04-17 - Biosensors Market Overwhelming Hike In Near Future With ...

KGaA, Ercon Inc., Xsensio, Analog Devices, Inc., Animas LLC, LifeSensors, Siemens, F. Hoffmann-La Roche Ltd, i-SENS, Inc., TaiDoc Technology...

2022-03-30 - Global Electronic Skin Market worth $16 Billion by 2026

Byteflies & Quad Industries, Xenoma Inc., Abbott Laboratories, Xsensio, Bloomlife, VivaLnK, Inc., and iRhythm among many others are some of...

2022-03-22 - Third Cohort of Mayo Clinic and Arizona State University MedTech Accelerator Commences

Xsensio, Switzerland: Xsensio develops the unique Lab-on-Skin™ sensing platform to sense in real time biochemical information at the surface...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.8M10-58%N/A
#2
$1.9M10150%N/A
#3
$2.3M11-21%N/A
#4
$0.7M1110%N/A
#5
$1M11-8%N/A